Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tavneos
Pharma
Amgen's ChemoCentryx prevails in investor lawsuit
ChemoCentryx has triumphed in a securities fraud complaint accusing the company of misleading investors about the benefit of its drug Tavneos.
Fraiser Kansteiner
Aug 19, 2025 10:13am
Lawsuit points to alleged misconduct at Amgen-bought biotech
Jul 25, 2025 11:18am
Amgen lays out plan to boost sales of newly acquired Tepezza
Oct 31, 2023 11:29am
Amgen bided its time to snatch up ChemoCentryx
Sep 1, 2022 10:55am
'The Top Line': Biogen's changes, most influential CEOs and more
May 6, 2022 6:15am
Wherefore Tavneos? ChemoCentryx and the Brand Institute explain
Apr 12, 2022 10:39am
